Asif, Sabaa, et al. “Posterior Reversible Leukoencephalopathy Syndrome in a Patient After Second Dose of Rituximab for Treatment of Resistant Thrombotic Thrombocytopenic Purpura”. Journal of Clinical Nephrology, vol. 2, no. 1, Feb. 2018, pp. 001-4, doi:10.29328/journal.jcn.1001010.